Homepage

We are a global leader in generic and biosimilar pharmaceuticals, committed to driving access to medicine
Bij Sandoz ontdekken we nieuwe manieren om het leven van mensen te verbeteren en te verlengen en ...

Explore Novartis

Sandoz announces agreement to acquire GSK’s cephalosporin antibiotics business, reinforcing its leading global position in antibiotics

Sandoz, a Novartis division, has signed an agreement to acquire GSK’s cephalosporin antibiotics business, reinforcing its leading global position in antibiotics. The agreement includes the global rights to three established brands (Zinnat®, Zinacef® and Fortum®)) in more than 100 markets. 

Novartis 2020 Financial Results

scientist and colleagues

Novartis announced fourth quarter and full year financial results for 2020 on January 26, 2021

Sandoz officially certified as Global Top Employer 2021

Sandoz, a Novartis division, is pleased to announce that it has been officially awarded “Global Top Employer 2021” certification for the third year in a row. This year, Sandoz was one of only 16 Top Employers recognized for their outstanding HR policies and practices worldwide by the Top Employers Institute.

Sandoz schenkt hydroxychloroquine tabletten aan België

De Novartis-groep heeft zich ertoe verbonden om wereldwijd 130 miljoen dosissen van het antimalariamiddel hydroxychloroquine te schenken ter ondersteuning van de strijd tegen de COVID-19 pandemie. België is één van de landen die deze schenking ontvangt. 

Bij Sandoz ontdekken we nieuwe manieren om het leven van mensen te verbeteren en te verlengen. We onderzoeken innovatieve benaderingen om mensen wereldwijd toegang te bieden tot hoogkwalitatieve geneesmiddelen.